Terms: = Colorectal cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Treatment
28 results:
1. Feature selection based on unsupervised clustering evaluation for predicting neoadjuvant chemoradiation response for patients with locally advanced rectal cancer.
Chen H; Li X; Pan X; Qiang Y; Qi XS
Phys Med Biol; 2023 Dec; 68(23):. PubMed ID: 37972413
[TBL] [Abstract] [Full Text] [Related]
2. Factors Associated with Receipt of Adjuvant Chemotherapy in Stage II Colon cancer.
Ginesi MC; Bliggenstorfer JT; Kwesiga DM; Xu SH; Jodeh D; Eva Selfridge J; Stein SL; Steinhagen EF
Ann Surg Oncol; 2023 Sep; 30(9):5511-5518. PubMed ID: 37249722
[TBL] [Abstract] [Full Text] [Related]
3. [The analysis of impact of medical social and economic factors on regional coloproctological morbidity of adult population].
Lisichkin AL
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2022 May; 30(3):402-406. PubMed ID: 35670394
[TBL] [Abstract] [Full Text] [Related]
4. NTRK fusion positive colorectal cancer is a unique subset of CRC with high TMB and microsatellite instability.
Wang H; Li ZW; Ou Q; Wu X; Nagasaka M; Shao Y; Ou SI; Yang Y
Cancer Med; 2022 Jul; 11(13):2541-2549. PubMed ID: 35506567
[TBL] [Abstract] [Full Text] [Related]
5. Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Colorectal Cancer Collaborators
Lancet Gastroenterol Hepatol; 2022 Jul; 7(7):627-647. PubMed ID: 35397795
[TBL] [Abstract] [Full Text] [Related]
6. Quality of Life After Bladder cancer: A Cross-sectional Survey of Patient-reported Outcomes.
Catto JWF; Downing A; Mason S; Wright P; Absolom K; Bottomley S; Hounsome L; Hussain S; Varughese M; Raw C; Kelly P; Glaser AW
Eur Urol; 2021 May; 79(5):621-632. PubMed ID: 33581875
[TBL] [Abstract] [Full Text] [Related]
7. Deletion of Cbl-b inhibits CD8
Kumar J; Kumar R; Kumar Singh A; Tsakem EL; Kathania M; Riese MJ; Theiss AL; Davila ML; Venuprasad K
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462140
[TBL] [Abstract] [Full Text] [Related]
8. The effect of body mass index on location of recurrence and survival in early-stage colorectal cancer.
Sakin A; Samanci NS; Secmeler S; Arici S; Can O; Yasar N; Geredeli C; Demir C; Cihan S
J Cancer Res Ther; 2020 Dec; 16(Supplement):S176-S182. PubMed ID: 33380674
[TBL] [Abstract] [Full Text] [Related]
9. Impact of travel distance on quality outcomes in colorectal cancer.
Spaulding AC; Borkar S; Osagiede O; Cochuyt JJ; Lemini R; Otto N; Colibaseanu DT
Am J Manag Care; 2020 Nov; 26(11):e347-e354. PubMed ID: 33196285
[TBL] [Abstract] [Full Text] [Related]
10. Insurance status and level of education predict disparities in receipt of treatment and survival for anal squamous cell carcinoma.
Patel KS; Alhatem A; Gadde U; Ahlawat S; Lambert C; Schwartz RA; Dalla Piazza M
Cancer Epidemiol; 2020 Aug; 67():101723. PubMed ID: 32408241
[TBL] [Abstract] [Full Text] [Related]
11. Gender comparison of clinical, histopathological, therapeutic and outcome factors in 185,967 colon cancer patients.
Schmuck R; Gerken M; Teegen EM; Krebs I; Klinkhammer-Schalke M; Aigner F; Pratschke J; Rau B; Benz S
Langenbecks Arch Surg; 2020 Feb; 405(1):71-80. PubMed ID: 32002628
[TBL] [Abstract] [Full Text] [Related]
12. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
[TBL] [Abstract] [Full Text] [Related]
13. pSILAC method coupled with two complementary digestion approaches reveals PRPF39 as a new E7070-dependent DCAF15 substrate.
Jia X; Pan L; Zhu M; Hu H; Zhai L; Liu J; Hu M; Liu B; Tan M
J Proteomics; 2020 Jan; 210():103545. PubMed ID: 31626998
[TBL] [Abstract] [Full Text] [Related]
14. Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal cancer (PARADAC).
Rivin Del Campo E; Matzinger O; Haustermans K; Peiffert D; Glynne-Jones R; Winter KA; Konski AA; Ajani JA; Bosset JF; Hannoun-Levi JM; Puyraveau M; Chakravarthy AB; Meadows H; Northover J; Collette L; Christiaens M; Maingon P
Eur J Cancer; 2019 Nov; 121():130-143. PubMed ID: 31574418
[TBL] [Abstract] [Full Text] [Related]
15. Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.
Margalit O; Mamtani R; Kopetz S; Yang YX; Lawrence YR; Abu-Gazala S; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
Oncologist; 2019 Aug; 24(8):e671-e676. PubMed ID: 30696723
[TBL] [Abstract] [Full Text] [Related]
16. Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer.
Ma WJ; Wang X; Yan WT; Zhou ZG; Pan ZZ; Chen G; Zhang RX
World J Gastroenterol; 2018 May; 24(20):2181-2190. PubMed ID: 29853736
[TBL] [Abstract] [Full Text] [Related]
17. Pelvic insufficiency fracture (PIF) incidence in patients treated with intensity-modulated radiation therapy (IMRT) for gynaecological or anal cancer: single-institution experience and review of the literature.
Bazire L; Xu H; Foy JP; Amessis M; Malhaire C; Cao K; De La Rochefordiere A; Kirova YM
Br J Radiol; 2017 May; 90(1073):20160885. PubMed ID: 28291401
[TBL] [Abstract] [Full Text] [Related]
18. Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate.
Feng YR; Jin J; Ren H; Wang X; Wang SL; Wang WH; Song YW; Liu YP; Tang Y; Li N; Liu XF; Fang H; Yu ZH; Li YX
BMC Cancer; 2017 Mar; 17(1):182. PubMed ID: 28279170
[TBL] [Abstract] [Full Text] [Related]
19. The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database.
Cheung WY; Shi Q; O'Connell M; Cassidy J; Blanke CD; Kerr DJ; Meyers J; Van Cutsem E; Alberts SR; Yothers G; Sargent DJ;
Clin Colorectal Cancer; 2013 Sep; 12(3):179-87. PubMed ID: 23810482
[TBL] [Abstract] [Full Text] [Related]
20. Are community hospitals meeting the same standards as academic hospitals for the multimodal management of rectal cancer?
Chiu CG; Hari DM; Leung AM; Yoon JL; Sim MS; Bilchik AJ
Am Surg; 2012 Oct; 78(10):1172-7. PubMed ID: 23189759
[TBL] [Abstract] [Full Text] [Related]
[Next]
